These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6338265)
21. The evaluation of the data collection process for a multicenter, population-based, case-control design. Wingo PA; Ory HW; Layde PM; Lee NC Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827 [TBL] [Abstract][Full Text] [Related]
22. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis. Jorgensen C; Picot MC; Bologna C; Sany J Ann Rheum Dis; 1996 Feb; 55(2):94-8. PubMed ID: 8712873 [TBL] [Abstract][Full Text] [Related]
23. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors. McTiernan AM; Weiss NS; Daling JR Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918 [TBL] [Abstract][Full Text] [Related]
24. Noncontraceptive health benefits of oral steroidal contraceptives. Mishell DR Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):809-16. PubMed ID: 7065059 [TBL] [Abstract][Full Text] [Related]
25. Epidemiology of endometriosis in women attending family planning clinics. Vessey MP; Villard-Mackintosh L; Painter R BMJ; 1993 Jan; 306(6871):182-4. PubMed ID: 8338516 [TBL] [Abstract][Full Text] [Related]
26. A prospective cohort study of oral contraceptives and cancer of the endometrium. Trapido EJ Int J Epidemiol; 1983 Sep; 12(3):297-300. PubMed ID: 6629618 [TBL] [Abstract][Full Text] [Related]
27. Sex hormones and cardiovascular risk. La Vecchia C Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926 [TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives and breast cancer. Brinton LA; Hoover R; Szklo M; Fraumeni JF Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784 [TBL] [Abstract][Full Text] [Related]
31. Oral contraceptives and breast cancer in young women. Stadel BV; Rubin GL; Webster LA; Schlesselman JJ; Wingo PA Lancet; 1985 Nov; 2(8462):970-3. PubMed ID: 2865503 [TBL] [Abstract][Full Text] [Related]
32. Oral contraceptive use and the risk of epithelial ovarian cancer. La Vecchia C; Franceschi S; Decarli A Br J Cancer; 1984 Jul; 50(1):31-4. PubMed ID: 6743513 [TBL] [Abstract][Full Text] [Related]
33. Risk factors for pathologically confirmed benign breast disease. Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913 [TBL] [Abstract][Full Text] [Related]
34. Risk factors for epithelial ovarian tumours of borderline malignancy. Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425 [TBL] [Abstract][Full Text] [Related]
35. Hormonal and reproductive influences and risk of melanoma in women. Smith MA; Fine JA; Barnhill RL; Berwick M Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729 [TBL] [Abstract][Full Text] [Related]
36. Comparing the health risks and benefits of contraceptive choices. Kost K; Forrest JD; Harlap S Fam Plann Perspect; 1991; 23(2):54-61. PubMed ID: 2060612 [TBL] [Abstract][Full Text] [Related]
37. Incidence of endometrial cancer in relation to the use of oral contraceptives. Weiss NS; Sayvetz TA N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890 [TBL] [Abstract][Full Text] [Related]
38. Age-specific differences in the relationship between oral contraceptive use and breast cancer. Wingo PA; Lee NC; Ory HW; Beral V; Peterson HB; Rhodes P Cancer; 1993 Feb; 71(4 Suppl):1506-17. PubMed ID: 8431887 [TBL] [Abstract][Full Text] [Related]
39. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183 [TBL] [Abstract][Full Text] [Related]